References
- 1. Antunes G, Evans SA, Lordan JL, Frew AJ. Systemic cytokines levels in community-acquired pneumonia and their association with disease severity. Eur Respir J. 2002 Oct;20 (4):990–5. DOI: 10.1183/09031936.02.0029510210.1183/09031936.02.0029510212412694
- 2. Community-Acquired Pneumonia (CAP): Practice Essentials, Overview, Etiology of Community-Acquired Pneumonia [Online]. [2017] [cited February 2020]; Available from: URL: https://emedicine.medscape.com/article/234240-overview.
- 3. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan;336(4):243–50. DOI: 10.1056/NEJM19970123336040210.1056/NEJM1997012333604028995086
- 4. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003 May;58(5):377–82. DOI: 10.1136/thorax.58.5.37710.1136/thorax.58.5.377174665712728155
- 5. [Online]. 2019 [cited February 2020]. Available from: URL: https://lifeinthefastlane.com/wp-content/uploads/2010/07/etg-smartcop.
- 6. Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, et al. Contribution of C-reactive protein to the diagnostic and assessment of severity of community-acquired pneumonia. Chest. 2004 Apr;125(4):1335–42. DOI: 10.1378/chest.125.4.133510.1378/chest.125.4.133515078743
- 7. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedlinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006 Jul;174(1):84–93. DOI: 10.1164/rccm.200512-1922OC10.1164/rccm.200512-1922OC16603606
- 8. Magnussen B, Oren Gradel K, Gorm Jensen T, Kolmos HJ, Pedersen C, Just Vinholt P, et al. Association between Hypoalbuminaemia and Mortality in Patients with Community-Acquired Bacteraemia Is Primarily Related to Acute Disorders. PLoS ONE. 2016 Sep;11(9): e0160466. DOI: 10.1371/journal. pone.0160466
- 9. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third International Consensus definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016 Feb;315(8):801–10. DOI: 10.1001/jama.2016.028710.1001/jama.2016.0287496857426903338
- 10. Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of SOFA score, SIRS criteria and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the Intensive Care Unit. JAMA. 2017 Jan;317(3):290–300. DOI: 10.1001/jama.2016.2032810.1001/jama.2016.2032828114553
- 11. Asai N, Watanabe H, Shiota A, Kato H, Sakanashi D, Hagihara M, et al. Efficacy and accuracy of q SOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia. Int J Infect Dis. 2019 Jul;84:89–96. DOI: 10.1016/j. ijid.2019.04.020
- 12. Tripon RE, Neagoe IB, Budisan L, Pop TL, Cristea V, Stanca LM, et al. Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes. Rev Romana Med Lab. 2019;27(2):189–98. DOI: 10.2478/rrlm-2019-002010.2478/rrlm-2019-0020
- 13. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respire Crit Care Med. 2019 Oct;200(7):e45–e67. DOI: 10.1164/rccm.201908-1581ST10.1164/rccm.201908-1581ST681243731573350
- 14. Bone R, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis. The ACCP/SCCM Consensus Conference Committee. Amrican College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992 Jun;101(6):1644–55. DOI: 10.1378/chest.101.6.164410.1378/chest.101.6.16441303622
- 15. Gutiérrez F, Masiá M, Mirete C, Soldán B, Carlos Rodríguez J, Padilla S, et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect. 2006 Sep;53(3):166–74. DOI: 10.1016/j.jinf.2005.11.00610.1016/j.jinf.2005.11.00616375972
- 16. Rozenbaum M, Mangen M, Huijts S, van der Werf T, Postma M. Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. Vaccine. 2015 Jun;33(28):3193–9. DOI: 10.1016/j.vaccine.2015.05.00110.1016/j.vaccine.2015.05.00125981488
- 17. Garau J, Baquero F, Pérez-Trallero E, Pérez J, Martín-Sánchez A, García-Rey C, et al. Factors impacting on length of stay and mortality of community-acquired pneumonia. Clin Microbiol Infect. 2008 Apr;14(4):322–9. DOI: 10.1111/j.1469-0691.2007.01915.x10.1111/j.1469-0691.2007.01915.x18190569
- 18. Song H, Moon GH, Kim HS. Efficacy of quick SOFA with lactate concentration for predicting mortality in patients with community-acquired pneumonia in the emergency department. Clin Exp Emerg Med. 2019 Mar;6(1):1–8. DOI: 10.15441/ceem.17.26210.15441/ceem.17.262645369830781940
- 19. Chen XY, Wang JY, Guo SB. Use of CRB-65 and quick SOFA to predict site of care and mortality in pneumonia patients in the emergency department: a retrospective study. Crit Care. 2016 Jun;20(1):167. DOI: 10.1186/s13054-016-1351-010.1186/s13054-016-1351-0488849527250351
- 20. Dosanjh DPS, Grudzinska F, Aldridge K, Hughes S, Thickett D. Risk stratification in community acquired pneumonia-CURB65, SIRS or qSOFA? A retrospective analysis. Thorax. 2017 Dec;72(Suppl 3): A8.2-A9. DOI: 10.1136/thoraxjnl-2017-210983.1410.1136/thoraxjnl-2017-210983.14
- 21. Tokioka F, Okamoto H, Yamazaki A, Itou A, Ishida T. The prognostic performance of qSOFA for community acquired pneumonia. J Intensive Care. 2018 Aug;6:46. DOI: 10.1186/s40560-018-0307-710.1186/s40560-018-0307-7608358430116532
- 22. Anhert P, Creutz P, Horn K, Schwarzenberger F, Kiehntopf M, Hossain H, et al. Sequential organ failure assessment score in an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia-results from the prospective observational PROGRESS study. Crit Care. 2019 Apr;23:110. DOI: 10.1186/s13054-019-2316-x10.1186/s13054-019-2316-x645000230947753
- 23. Shaddock EJ. How and when to use common biomarkers in community-acquired pneumonia. Pneumonia (Nathan). 2016 Oct;8:17. DOI: 10.1186/s41479-016-0017-710.1186/s41479-016-0017-7547170428702296
- 24. Naderi HR, Sheybani F, Sarvghad M, Nooghabi MJ. Can procalcitonin add to the prognostic power of the severity scoring system in adults with pneumonia? Tanaffos. 2015;14(2):95–106.
- 25. Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med. 2008 Mar;121(3):219–25. DOI: 10.1016/j.amjmed.2007.10.03310.1016/j.amjmed.2007.10.03318328306
- 26. Thiem U, Niklaus D, Sehloff B, Stuckle C, Heppner HJ, Endres HG, et al. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Age Ageing. 2009 Nov;38(6):693–7. DOI: 10.1093/ageing/afp16410.1093/ageing/afp16419729453
- 27. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000 Oct;85(4):599–610. DOI: 10.1093/bja/85.4.59910.1093/bja/85.4.59911064620
- 28. Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, et al. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. J Crit Care. 2011 Jun;26(3):287–94. DOI: 10.1016/j.jcrc.2010.10.00710.1016/j.jcrc.2010.10.00721129911
- 29. Viasus D, Garcia-Vidal C, Simionetti A, Manresa F, Dorca J, Gudoil F, et al. Prognostic value of serum albumin levels in hospitalized adults with community-acquired pneumonia. J Infect. 2013 May;66(5):415–23. DOI: 10.1016/j.jinf.2012.12.00710.1016/j.jinf.2012.12.00723286966
- 30. Magnussen B, Oren Gradel K, Gorm JT, Kolmos HJ, Pedersen C, Just Vinholt P, et al. Association between hypoalbuminemia and mortality in patients with community-acquired bacteraemia is primarily related to acute disorders. PLos One. 2016 Sep;11(9):e0160466. DOI: 10.1371/journal.pone.016046610.1371/journal.pone.0160466501770427611431